The assembly endorsed a decision that the shareholders be paid a dividend in the amount of 12 kuna per share from the retained profit from previous years, with the profit for the year 2005 in the amount of 33.7 million kuna being appropriated to retained profit.
On this occasion, the company's CEO, Zeljko Covic, said that all decisions the management made concerning the prospective takeover of Pliva by other companies were motivated by plans to raise a price of Pliva shares.
Answering reporters' questions after the end of the general meeting, Covic said that all that the management had done was in the interest of shareholders and that was why the management ensured competition in the process of acquisition of Pliva.
Now it is up to the Supervisory Board to express positions on possible acquisitions, Covic said.
The U.S Barr Pharmaceuticals and the Iceland-based Actavis have so far expressed interest in taking over Pliva.